Angiotensin-Converting Enzyme-2 (ACE2), SARS-CoV-2 and Pathophysiology of Coronavirus Disease 2019 (COVID-19) - Paris Redox World Congress 2022 - June 22- 24, 2022

Redox-2022-banner-v2

Angiotensin-Converting Enzyme-2 (ACE2), SARS-CoV-2 and Pathophysiology of Coronavirus Disease 2019 (COVID-19)

Paris-Redox-2020-Speakers-Harry-van-goor

Prof. Harry van Goor, President of ISANH from University Medical Center, the Netherlands will also talk about "Angiotensin-Converting Enzyme-2 (ACE2), SARS-CoV-2 and Pathophysiology of Coronavirus Disease 2019 (COVID-19)" during the Paris Redox 2020 Virtual Congress.

In this presentation, an introduction will be given to  COVID-19 disease. We will among others discuss ACE2, TMPRSS2 and the pathophysiology of COVID-19. Furthermore, we will give attention to inflammation, coagulation and oxidative stress in COVID-19. Current strategies for pharmaceutical intervention will be discussed as well.


Paris Redox 2020 Congress
October 8-9, 2020 - Virtual Congress
www.isanh.net

Redox in the Press & Media

  • 1
  • 2
Prev Next